Taking the example of TCM treatment of non small-cell lung cancer (NSCLC), the article discusses timing of TCM intervention during peri-operation of malignant tumor, handling of excessive treatment, treatment strategy for advanced cancer stage of the aged. Moreover, explore the status quo and prospect of objectification of the syndromes of malignant tumor and standardization of efficacy evaluation.